wound-care-microbiology-2019-keynote

2 / 7

Page 13
allied
academies
Joint Event
February 21-22, 2019 | Paris, France
Microbiology & Applied
Microbiology
2nd International Conference on World Congress on
Wound Care, Tissue Repair
and Regenerative Medicine
&
Nowadays, ultrasonic wound and skin treatments, especially
those which aid in infection control, have been gaining the
interest of hospitals, clinics, wound care centers and doctors’
offices worldwide. The purpose of this presentation is to
introduce upcoming advances in ultrasonic wound therapy, as
well as to share, review and evaluate the expected efficacy of
ultrasound therapies in treating all types of acute and chronic
wounds. This includes battlefield wound treatment and the
topical oxygenation of wounds and body parts with ultrasound.
For wound treatment purposes, both low and high frequency
ultrasound devices will used in the near future. For example,
Arobella Medical has designed:
1. (Patented and FDA approved) The Qoustic Panacea® AS
-1000 is the next wound care product based on the use of
ultrasonic energy to mix oxygen and saline in real-time. This
allows for ultrasound delivery to the wound bed and topical
oxygenation of various parts of the body. Slides and videos will
be demonstrated during presentation.
2. Portable Wound Therapy System AF 1000 series to provide
a portable ultrasound device for the treatment of wounds.
This system is suitable for military use in the battlefield for
immediate treatment of wounded soldiers. Additionally, the
device’s small size, portability, and low weight enable its use
in field surgery, where equipment is often limited. The device
cauterizes the wound, stops bleeding, greatly reduces pain, and
prevents infection. The Portable Wound therapy system has
several therapeutic effects and can remove bullets or shrapnel
from a wound, making it useful in battlefields, terrorist attacks
and other disaster areas, such as crashes, etc. This device can
be used by a variety of emergency personnel whether in an
ambulance or an antiterrorism operation. Slides and videos will
be demonstrated during presentation.
3. BA-1000 Skin Care Device and Method: The BA-1000 is an
ultrasound assisted, cryogenic ablation device that enables
tissue to be frozen and ablated at zero degrees Celsius.
Generally, tissue ablation is performed at negative fifty degrees
Celsius. This device is going to be used for warts, skin disorders
(scars), Human papillomavirus and later for tumor removal with
reduced discoloration, less scarring, minimal regrowth, faster
healing and less pain in comparison with existing technologies
such a laser, cryo, etc. Ablating tissue at a warmer temperature,
the exact freezing point of water, limits damage to surrounding
tissue and provides a safer procedure.
4. Osteomyelitis Treatment: Osteomyelitis is an infection of
bone marrow. Standard treatment involves surgically opening
the bone and scraping away infectedmarrow. ArobellaMedical
has developed a technology that enables a significantly less
invasive treatment of the disease. This device is protected by
issued US patents.
5.ArobellaMedicalhasdevelopedultrasoundtechnologyforuse
in combination with varying degrees of pressure and/or suction
(Negative Pressure Wound Therapy + ultrasound and Positive
Pressure Wound Therapy + ultrasound) as an all-in-one device
for accelerating tissue healing in patients. The use of ultrasound
by medical personnel for wound treatment provides benefits of
improved efficiency, faster healing, selective debridement and
less pain during and after the procedure.
6. Different companies including Arobella Medical are working
on high frequency ultrasound devices for wound therapy.
7. Ultrasonic Infection Control: A patented hand washing or
sterilization device for use before surgery in operating rooms.
Other applications include kitchens, stores, toilets, and public
areas.
During the presentationmany other expected future ultrasound
technologies and devices will be discussed.
Speaker Biography
Eliaz Babaev, co-founded Arobella Medical, LLC in 2006 and serves as its chief executive
officer and President. He co-founded Celleration Inc. and served as its chief technical
officer until July 2009. He worked as an ultrasound system design engineer and research
scientist for DiaSorin, Inc., SpectRx, and AeroPag-USA, Inc. He served as the head of
Biomedical Engineering Laboratory and a professor for State Technical University,
Baku, USSR for 25 years. He has more than 40+ years expertise in non-Imaging medical
ultrasound and particularly in ultrasound wound management, live tissue repair and
in all the areas of advances in skin, wound care, nursing, tissue science, drug delivery
systems, wound treatment technologies, tissue engineering, and body architectonics
research and cancer research including apoptosis. 50 + US and 100 + worldwide patents
are issued, numerous are pending, 50+ scientific articles, abstracts are published.
e:
Eliaz Babaev
Arobella Medical LLC, USA
Future of ultrasound wound therapy: Technologies, devices, science and clinical
outcomes
Eliaz Babaev, J Trauma Crit Care, Volume 3
DOI: 10.4066/2591-7358-C1-001
Journal of Trauma and Critical Care | Volume 3